Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Effectiveness of Extracorporeal Shock Wave Therapy as an Adjunct to Botulinum Toxin Injection in Patients With Post-Stroke Ankle Plantar Flexor Spasticity: A Randomized Controlled Trial

NCT07695038 is registered in ClinicalTrials.gov with Pamukkale University as lead sponsor.

NCT NCT07695038
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT07695038 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Effectiveness of Extracorporeal Shock Wave Therapy as an Adjunct to Botulinum Toxin Injection in Patients With Post-Stroke Ankle Plantar Flexor Spasticity: A Randomized Controlled Trial
Lead sponsor
Pamukkale University
Phase
Not applicable
Overall status
Not yet recruiting
Start date
July 20, 2026
Completion date
August 20, 2027
Enrollment
32 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

post-stroke spasticity, post-stroke spasticity of the lower limb, spasticity of the plantar flexors, spasticity, post-stroke, stroke